drugset
drugset / Trial / NCT01545843

Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression

NCT01545843 ↗

Phase 2 Completed 68 enrolled University of Michigan
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to determine whether changing sleep patterns improves response to an antidepressant medication.

Timeline

Start
2009-03
Primary completion
2012-12
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 20 mg —
Subject Fluoxetine Small molecule 40 mg —

Indications

depressive disorder